<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36768220</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>18</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>SOMAscan Proteomics Identifies Novel Plasma Proteins in Amyotrophic Lateral Sclerosis Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1899</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24031899</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a complex disease characterized by the interplay of genetic and environmental factors for which, despite decades of intense research, diagnosis remains rather delayed, and most therapeutic options fail. Therefore, unravelling other potential pathogenetic mechanisms and searching for reliable markers are high priorities. In the present study, we employ the SOMAscan assay, an aptamer-based proteomic technology, to determine the circulating proteomic profile of ALS patients. The expression levels of ~1300 proteins were assessed in plasma, and 42 proteins with statistically significant differential expression between ALS patients and healthy controls were identified. Among these, four were upregulated proteins, Thymus- and activation-regulated chemokine, metalloproteinase inhibitor 3 and nidogen 1 and 2 were selected and validated by enzyme-linked immunosorbent assays in an overlapping cohort of patients. Following statistical analyses, different expression patterns of these proteins were observed in the familial and sporadic ALS patients. The proteins identified in this study might provide insight into ALS pathogenesis and represent potential candidates to develop novel targeted therapies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Berrone</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-1731-4810</Identifier><AffiliationInfo><Affiliation>S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiorino</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9502-6400</Identifier><AffiliationInfo><Affiliation>Cancer Genomics Laboratory, Fondazione Edo ed Elvo Tempia, 13900 Biella, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guana</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-9358-5949</Identifier><AffiliationInfo><Affiliation>Cancer Genomics Laboratory, Fondazione Edo ed Elvo Tempia, 13900 Biella, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benedetti</LastName><ForeName>Valerio</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-1817-6931</Identifier><AffiliationInfo><Affiliation>S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmitessa</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallo</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5122-7243</Identifier><AffiliationInfo><Affiliation>Rita Levi Montalcini Department of Neuroscience, University of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology, Hospital Department of Neuroscience and Mental Health, Citt&#xe0; della Salute e della Scienza Hospital of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casale</LastName><ForeName>Federico</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-1097-1279</Identifier><AffiliationInfo><Affiliation>Rita Levi Montalcini Department of Neuroscience, University of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manera</LastName><ForeName>Umberto</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0002-9995-8133</Identifier><AffiliationInfo><Affiliation>Rita Levi Montalcini Department of Neuroscience, University of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology, Hospital Department of Neuroscience and Mental Health, Citt&#xe0; della Salute e della Scienza Hospital of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Favole</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4110-4327</Identifier><AffiliationInfo><Affiliation>S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crociara</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ASL TO4, 10034 Chivasso, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Testori</LastName><ForeName>Camilla</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8839-3544</Identifier><AffiliationInfo><Affiliation>S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carta</LastName><ForeName>Valerio</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tessarolo</LastName><ForeName>Carlotta</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3711-3722</Identifier><AffiliationInfo><Affiliation>S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Angelo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5924-8882</Identifier><AffiliationInfo><Affiliation>Department of Veterinary Science, University of Turin, 10095 Grugliasco, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Marco</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-3966-8695</Identifier><AffiliationInfo><Affiliation>Rita Levi Montalcini Department of Neuroscience, University of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology, Hospital Department of Neuroscience and Mental Health, Citt&#xe0; della Salute e della Scienza Hospital of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caramelli</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi&#xf2;</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rita Levi Montalcini Department of Neuroscience, University of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology, Hospital Department of Neuroscience and Mental Health, Citt&#xe0; della Salute e della Scienza Hospital of Turin, 10126 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casalone</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corona</LastName><ForeName>Cristiano</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2895-0828</Identifier><AffiliationInfo><Affiliation>S.C. Neuroscienze, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d'Aosta, 10154 Turin, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CRT 2017.0891</GrantID><Agency>CRT Foundation</Agency><Country/></Grant><Grant><GrantID>20CEA</GrantID><Agency>Italian Ministry of Health</Agency><Country/></Grant><Grant><GrantID>1157625</GrantID><Agency>POR FESR 2014-2020</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001798">Blood Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001798" MajorTopicYN="N">Blood Proteins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">SOMAscan</Keyword><Keyword MajorTopicYN="N">TARC</Keyword><Keyword MajorTopicYN="N">TIMP-3</Keyword><Keyword MajorTopicYN="N">nidogen</Keyword><Keyword MajorTopicYN="N">plasma proteins</Keyword></KeywordList><CoiStatement>E.B., F.G., V.B., C.P., M.G., F.C., U.M., A.F., P.C., C.T. (Camilla Testori), V.C., C.T. (Carlotta Tessarolo), A.D., G.D., M.C., G.C., C.C. (Cristina Casalone) and C.C. (Cristiano Corona) declare no conflict of interest. A.C. (Andrea Calvo) received a research grant from Cytokinetics. A.C. (Adriano Chi&#xf2;) serves on scientific advisory boards for Mitsubishi Tanabe, Biogen, Roche, Denali Pharma, Cytokinetics, Lilly and Amylyx Pharmaceuticals and received a research grant from Biogen. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36768220</ArticleId><ArticleId IdType="pmc">PMC9916400</ArticleId><ArticleId IdType="doi">10.3390/ijms24031899</ArticleId><ArticleId IdType="pii">ijms24031899</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rothstein J.D., Martin L.J., Kuncl R.W. Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 1992;326:1464&#x2013;1468. doi: 10.1056/NEJM199205283262204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199205283262204</ArticleId><ArticleId IdType="pubmed">1349424</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., Horton D.K., Kasarskis E.J., Tessaro E., Eisenberg M.S., Laird S., Iskander J. CDC Grand Rounds: National Amyotrophic Lateral Sclerosis (ALS) Registry Impact, Challenges, and Future Directions. MMWR Morb. Mortal Wkly. Rep. 2017;66:1379&#x2013;1382. doi: 10.15585/mmwr.mm6650a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6650a3</ArticleId><ArticleId IdType="pmc">PMC5751576</ArticleId><ArticleId IdType="pubmed">29267263</ArticleId></ArticleIdList></Reference><Reference><Citation>Su W.-M., Cheng Y.-F., Jiang Z., Duan Q.-Q., Yang T.-M., Shang H.-F., Chen Y.-P. Predictors of Survival in Patients with Amyotrophic Lateral Sclerosis: A Large Meta-Analysis. EBioMedicine. 2021;74:103732. doi: 10.1016/j.ebiom.2021.103732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103732</ArticleId><ArticleId IdType="pmc">PMC8646173</ArticleId><ArticleId IdType="pubmed">34864363</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsultan A.A., Waller R., Heath P.R., Kirby J. The Genetics of Amyotrophic Lateral Sclerosis: Current Insights. Degener. Neurol. Neuromuscul. Dis. 2016;6:49&#x2013;64. doi: 10.2147/DNND.S84956.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DNND.S84956</ArticleId><ArticleId IdType="pmc">PMC6053097</ArticleId><ArticleId IdType="pubmed">30050368</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddique T., Ajroud-Driss S. Familial Amyotrophic Lateral Sclerosis, a Historical Perspective. Acta Myol. 2011;30:117&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3235825</ArticleId><ArticleId IdType="pubmed">22106714</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi M. Amyotrophic Lateral Sclerosis Mimic Syndromes. Iran. J. Neurol. 2016;15:85&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4912674</ArticleId><ArticleId IdType="pubmed">27326363</ArticleId></ArticleIdList></Reference><Reference><Citation>Bereman M.S., Beri J., Enders J.R., Nash T. Machine Learning Reveals Protein Signatures in CSF and Plasma Fluids of Clinical Value for ALS. Sci. Rep. 2018;8:16334. doi: 10.1038/s41598-018-34642-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34642-x</ArticleId><ArticleId IdType="pmc">PMC6218542</ArticleId><ArticleId IdType="pubmed">30397248</ArticleId></ArticleIdList></Reference><Reference><Citation>Conraux L., Pech C., Guerraoui H., Loyaux D., Ferrara P., Guillemot J.-C., Meininger V., Pradat P.-F., Salachas F., Bruneteau G., et al. Plasma Peptide Biomarker Discovery for Amyotrophic Lateral Sclerosis by MALDI-TOF Mass Spectrometry Profiling. PLoS ONE. 2013;8:e79733. doi: 10.1371/journal.pone.0079733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079733</ArticleId><ArticleId IdType="pmc">PMC3818176</ArticleId><ArticleId IdType="pubmed">24224000</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma A.S., de Carvalho M., Grammel N., Pinto S., Barata N., Conradt H.S., Costa J. Proteomic Analysis of Plasma from Portuguese Patients with Familial Amyotrophic Lateral Sclerosis. Amyotroph. Lateral Scler. 2008;9:339&#x2013;349. doi: 10.1080/17482960801934239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960801934239</ArticleId><ArticleId IdType="pubmed">18608108</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubiri I., Lombardi V., Bremang M., Mitra V., Nardo G., Adiutori R., Lu C.-H., Leoni E., Yip P., Yildiz O., et al. Tissue-Enhanced Plasma Proteomic Analysis for Disease Stratification in Amyotrophic Lateral Sclerosis. Mol. Neurodegener. 2018;13:60. doi: 10.1186/s13024-018-0292-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0292-2</ArticleId><ArticleId IdType="pmc">PMC6223075</ArticleId><ArticleId IdType="pubmed">30404656</ArticleId></ArticleIdList></Reference><Reference><Citation>Brancia C., Noli B., Boido M., Boi A., Puddu R., Borghero G., Marrosu F., Bongioanni P., Orr&#xf9; S., Manconi B., et al. VGF Protein and Its C-Terminal Derived Peptides in Amyotrophic Lateral Sclerosis: Human and Animal Model Studies. PLoS ONE. 2016;11:e0164689. doi: 10.1371/journal.pone.0164689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0164689</ArticleId><ArticleId IdType="pmc">PMC5063282</ArticleId><ArticleId IdType="pubmed">27737014</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Robberecht W. Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Glial Activation in Motor Neuron Disease. Lancet Neurol. 2011;10:253&#x2013;263. doi: 10.1016/S1474-4422(11)70015-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70015-1</ArticleId><ArticleId IdType="pubmed">21349440</ArticleId></ArticleIdList></Reference><Reference><Citation>Robelin L., Gonzalez De Aguilar J.L. Blood Biomarkers for Amyotrophic Lateral Sclerosis: Myth or Reality? Biomed. Res. Int. 2014;2014:525097. doi: 10.1155/2014/525097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/525097</ArticleId><ArticleId IdType="pmc">PMC4060749</ArticleId><ArticleId IdType="pubmed">24991560</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C., Kiddle S.J., Mangino M., Vi&#xf1;uela A., Psatha M., Steves C., Sattlecker M., Buil A., Newhouse S., Nelson S., et al. Circulating Proteomic Signatures of Chronological Age. J. Gerontol. A Biol. Sci. Med. Sci. 2015;70:809&#x2013;816. doi: 10.1093/gerona/glu121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glu121</ArticleId><ArticleId IdType="pmc">PMC4469006</ArticleId><ArticleId IdType="pubmed">25123647</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka T., Biancotto A., Moaddel R., Moore A.Z., Gonzalez-Freire M., Aon M.A., Candia J., Zhang P., Cheung F., Fantoni G., et al. Plasma Proteomic Signature of Age in Healthy Humans. Aging Cell. 2018;17:e12799. doi: 10.1111/acel.12799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12799</ArticleId><ArticleId IdType="pmc">PMC6156492</ArticleId><ArticleId IdType="pubmed">29992704</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathyan S., Ayers E., Gao T., Weiss E.F., Milman S., Verghese J., Barzilai N. Plasma Proteomic Profile of Age, Health Span, and All-Cause Mortality in Older Adults. Aging Cell. 2020;19:e13250. doi: 10.1111/acel.13250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13250</ArticleId><ArticleId IdType="pmc">PMC7681045</ArticleId><ArticleId IdType="pubmed">33089916</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong T.G., Chan N.Y., Dillon S.T., Zhou W., Tripp B., Ngo L.H., Otu H.H., Inouye S.K., Vasunilashorn S.M., Cooper Z., et al. Identification of Plasma Proteome Signatures Associated With Surgery Using SOMAscan. Ann. Surg. 2021;273:732&#x2013;742. doi: 10.1097/SLA.0000000000003283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000003283</ArticleId><ArticleId IdType="pmc">PMC6832727</ArticleId><ArticleId IdType="pubmed">30946084</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasunilashorn S.M., Dillon S.T., Chan N.Y., Fong T.G., Joseph M., Tripp B., Xie Z., Ngo L.H., Lee C.G., Elias J.A., et al. Proteome-Wide Analysis Using SOMAscan Identifies and Validates Chitinase-3-Like Protein 1 as a Risk and Disease Marker of Delirium among Older Adults Undergoing Major Elective Surgery. J. Gerontol. A Biol. Sci. Med. Sci. 2022;77:484&#x2013;493. doi: 10.1093/gerona/glaa326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glaa326</ArticleId><ArticleId IdType="pmc">PMC8893174</ArticleId><ArticleId IdType="pubmed">35239952</ArticleId></ArticleIdList></Reference><Reference><Citation>Dammer E.B., Ping L., Duong D.M., Modeste E.S., Seyfried N.T., Lah J.J., Levey A.I., Johnson E.C.B. Multi-Platform Proteomic Analysis of Alzheimer&#x2019;s Disease Cerebrospinal Fluid and Plasma Reveals Network Biomarkers Associated with Proteostasis and the Matrisome. Alzheimers Res. 2022;14:174. doi: 10.1186/s13195-022-01113-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-022-01113-5</ArticleId><ArticleId IdType="pmc">PMC9670630</ArticleId><ArticleId IdType="pubmed">36384809</ArticleId></ArticleIdList></Reference><Reference><Citation>Dillon S.T., Otu H.H., Ngo L.H., Fong T.G., Vasunilashorn S.M., Xie Z., Kunze L.J., Vlassakov K.v., Abdeen A., Lange J.K., et al. Patterns and Persistence of Perioperative Plasma and Cerebrospinal Fluid Neuroinflammatory Protein Biomarkers After Elective Orthopedic Surgery Using SOMAscan. Anesth. Analg. 2023;136:163&#x2013;175. doi: 10.1213/ANE.0000000000005991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005991</ArticleId><ArticleId IdType="pmc">PMC9537343</ArticleId><ArticleId IdType="pubmed">35389379</ArticleId></ArticleIdList></Reference><Reference><Citation>Candia J., Daya G.N., Tanaka T., Ferrucci L., Walker K.A. Assessment of Variability in the Plasma 7k SomaScan Proteomics Assay. Sci. Rep. 2022;12:17147. doi: 10.1038/s41598-022-22116-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-22116-0</ArticleId><ArticleId IdType="pmc">PMC9561184</ArticleId><ArticleId IdType="pubmed">36229504</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gall L., Anakor E., Connolly O., Vijayakumar U.G., Duddy W.J., Duguez S. Molecular and Cellular Mechanisms Affected in ALS. J. Pers. Med. 2020;10:101. doi: 10.3390/jpm10030101.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm10030101</ArticleId><ArticleId IdType="pmc">PMC7564998</ArticleId><ArticleId IdType="pubmed">32854276</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial Revisited: Revised Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Boylan K. Familial Amyotrophic Lateral Sclerosis. Neurol. Clin. 2015;33:807&#x2013;830. doi: 10.1016/j.ncl.2015.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.001</ArticleId><ArticleId IdType="pmc">PMC4670044</ArticleId><ArticleId IdType="pubmed">26515623</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzog V., Kirfel G., Siemes C., Schmitz A. Biological Roles of APP in the Epidermis. Eur. J. Cell Biol. 2004;83:613&#x2013;624. doi: 10.1078/0171-9335-00401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1078/0171-9335-00401</ArticleId><ArticleId IdType="pubmed">15679106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiuchi Y., Isobe Y., Fukushima K. Entactin-Induced Inhibition of Human Amyloid &#x3b2;-Protein Fibril Formation in Vitro. Neurosci. Lett. 2001;305:119&#x2013;122. doi: 10.1016/S0304-3940(01)01831-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(01)01831-6</ArticleId><ArticleId IdType="pubmed">11376898</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Hundelshausen P., Agten S.M., Eckardt V., Blanchet X., Schmitt M.M., Ippel H., Neideck C., Bidzhekov K., Leberzammer J., Wichapong K., et al. Chemokine Interactome Mapping Enables Tailored Intervention in Acute and Chronic Inflammation. Sci. Transl. Med. 2017;9:eaah6650. doi: 10.1126/scitranslmed.aah6650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aah6650</ArticleId><ArticleId IdType="pubmed">28381538</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce W.H., Shively V.P. Abdominal Aortic Aneurysm as a Complex Multifactorial Disease: Interactions of Polymorphisms of Inflammatory Genes, Features of Autoimmunity, and Current Status of MMPs. Ann. N. Y. Acad. Sci. 2006;1085:117&#x2013;132. doi: 10.1196/annals.1383.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1383.025</ArticleId><ArticleId IdType="pubmed">17182928</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy R., Zhang B., Moses M. Making the Cut: Protease-Mediated Regulation of Angiogenesis. Exp. Cell Res. 2006;312:608&#x2013;622. doi: 10.1016/j.yexcr.2005.11.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2005.11.022</ArticleId><ArticleId IdType="pubmed">16442099</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro S.D. Matrix Metalloproteinase Degradation of Extracellular Matrix: Biological Consequences. Curr. Opin. Cell. Biol. 1998;10:602&#x2013;608. doi: 10.1016/S0955-0674(98)80035-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0955-0674(98)80035-5</ArticleId><ArticleId IdType="pubmed">9818170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Cang S., Li G., Su Y., Zhang H., Wang L., Yang J., Shi X., Qin G., Yuan H. Integrated Analysis of Transcriptome Data Revealed MMP3 and MMP13 as Critical Genes in Anaplastic Thyroid Cancer Progression. J. Cell Physiol. 2019;234:22260&#x2013;22271. doi: 10.1002/jcp.28793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.28793</ArticleId><ArticleId IdType="pubmed">31081124</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Wu Q., Qiu P., Mirza A., McGuirk M., Kirschmeier P., Greene J.R., Wang Y., Pickett C.B., Liu S. Analyses of P53 Target Genes in the Human Genome by Bioinformatic and Microarray Approaches. J. Biol. Chem. 2001;276:43604&#x2013;43610. doi: 10.1074/jbc.M106570200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M106570200</ArticleId><ArticleId IdType="pubmed">11571296</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Mirza A., Wang L. Checkpoint Controls and Cancer. Humana Press; Totowa, NJ, USA: 2004. Generation of P53 Target Database via Integration of Microarray and Global P53 DNA-Binding Site Analysis; pp. 33&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">15220520</ArticleId></ArticleIdList></Reference><Reference><Citation>Corniola R.S., Tassabehji N.M., Hare J., Sharma G., Levenson C.W. Zinc Deficiency Impairs Neuronal Precursor Cell Proliferation and Induces Apoptosis via P53-Mediated Mechanisms. Brain Res. 2008;1237:52&#x2013;61. doi: 10.1016/j.brainres.2008.08.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2008.08.040</ArticleId><ArticleId IdType="pubmed">18778698</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenlee K.J., Corry D.B., Engler D.A., Matsunami R.K., Tessier P., Cook R.G., Werb Z., Kheradmand F. Proteomic Identification of In Vivo Substrates for Matrix Metalloproteinases 2 and 9 Reveals a Mechanism for Resolution of Inflammation. J. Immunol. 2006;177:7312&#x2013;7321. doi: 10.4049/jimmunol.177.10.7312.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.10.7312</ArticleId><ArticleId IdType="pmc">PMC2580826</ArticleId><ArticleId IdType="pubmed">17082650</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei C.-L., Wu Q., Vega V.B., Chiu K.P., Ng P., Zhang T., Shahab A., Yong H.C., Fu Y., Weng Z., et al. A Global Map of P53 Transcription-Factor Binding Sites in the Human Genome. Cell. 2006;124:207&#x2013;219. doi: 10.1016/j.cell.2005.10.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.10.043</ArticleId><ArticleId IdType="pubmed">16413492</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohyagi Y., Asahara H., Chui D.-H., Tsuruta Y., Sakae N., Miyoshi K., Yamada T., Kikuchi H., Taniwaki T., Murai H., et al. Intracellular A&#x3b2;42 Activates P53 Promoter: A Pathway to Neurodegeneration in Alzheimer&#x2019;s Disease. FASEB J. 2005;19:1&#x2013;29. doi: 10.1096/fj.04-2637fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.04-2637fje</ArticleId><ArticleId IdType="pubmed">15548589</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarasi M., Janssen A., Weber B.H.F., St&#xf6;hr H. Molecular Dissection of TIMP3 Mutation S156C Associated with Sorsby Fundus Dystrophy. Matrix Biol. 2008;27:381&#x2013;392. doi: 10.1016/j.matbio.2008.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2008.01.008</ArticleId><ArticleId IdType="pubmed">18295466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kn&#xe4;uper V., Cowell S., Smith B., L&#xf3;pez-Otin C., O&#x2019;Shea M., Morris H., Zardi L., Murphy G. The Role of the C-Terminal Domain of Human Collagenase-3 (MMP-13) in the Activation of Procollagenase-3, Substrate Specificity, and Tissue Inhibitor of Metalloproteinase Interaction. J. Biol. Chem. 1997;272:7608&#x2013;7616. doi: 10.1074/jbc.272.12.7608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.12.7608</ArticleId><ArticleId IdType="pubmed">9065415</ArticleId></ArticleIdList></Reference><Reference><Citation>Kn&#xe4;uper V., L&#xf3;pez-Otin C., Smith B., Knight G., Murphy G. Biochemical Characterization of Human Collagenase-3. J. Biol. Chem. 1996;271:1544&#x2013;1550. doi: 10.1074/jbc.271.3.1544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.3.1544</ArticleId><ArticleId IdType="pubmed">8576151</ArticleId></ArticleIdList></Reference><Reference><Citation>Knauper V., Smith B., Lopez-Otin C., Murphy G. Activation of Progelatinase B (ProMMP-9) by Active Collagenase-3 (MMP-13) Eur. J. Biochem. 1997;248:369&#x2013;373. doi: 10.1111/j.1432-1033.1997.00369.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-1033.1997.00369.x</ArticleId><ArticleId IdType="pubmed">9346290</ArticleId></ArticleIdList></Reference><Reference><Citation>Vempati P., Karagiannis E.D., Popel A.S. A Biochemical Model of Matrix Metalloproteinase 9 Activation and Inhibition. J. Biol. Chem. 2007;282:37585&#x2013;37596. doi: 10.1074/jbc.M611500200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M611500200</ArticleId><ArticleId IdType="pubmed">17848556</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucker S., Vacirca J. Role of Matrix Metalloproteinases (MMPs) in Colorectal Cancer. Cancer Metastasis Rev. 2004;23:101&#x2013;117. doi: 10.1023/A:1025867130437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1025867130437</ArticleId><ArticleId IdType="pubmed">15000152</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreier R., Gr&#xe4;ssel S., Fuchs S., Schaumburger J., Bruckner P. Pro-MMP-9 Is a Specific Macrophage Product and Is Activated by Osteoarthritic Chondrocytes via MMP-3 or a MT1-MMP/MMP-13 Cascade. Exp. Cell Res. 2004;297:303&#x2013;312. doi: 10.1016/j.yexcr.2004.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2004.02.027</ArticleId><ArticleId IdType="pubmed">15212936</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummins P.M., von Offenberg Sweeney N., Killeen M.T., Birney Y.A., Redmond E.M., Cahill P.A. Cyclic Strain-Mediated Matrix Metalloproteinase Regulation within the Vascular Endothelium: A Force to Be Reckoned With. Am. J. Physiol.-Heart Circ. Physiol. 2007;292:H28&#x2013;H42. doi: 10.1152/ajpheart.00304.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00304.2006</ArticleId><ArticleId IdType="pubmed">16951049</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y.-P., Yan C., Zhou L., Qin L., Tsukamoto H. A Matrix Metalloproteinase-9 Activation Cascade by Hepatic Stellate Cells in Trans-Differentiation in the Three-Dimensional Extracellular Matrix. J. Biol. Chem. 2007;282:12928&#x2013;12939. doi: 10.1074/jbc.M700554200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M700554200</ArticleId><ArticleId IdType="pmc">PMC2376818</ArticleId><ArticleId IdType="pubmed">17322299</ArticleId></ArticleIdList></Reference><Reference><Citation>Swets J.A. Measuring the Accuracy of Diagnostic Systems. Science. 1988;240:1285&#x2013;1293. doi: 10.1126/science.3287615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3287615</ArticleId><ArticleId IdType="pubmed">3287615</ArticleId></ArticleIdList></Reference><Reference><Citation>Petricoin E.F., Belluco C., Araujo R.P., Liotta L.A. The Blood Peptidome: A Higher Dimension of Information Content for Cancer Biomarker Discovery. Nat. Rev. Cancer. 2006;6:961&#x2013;967. doi: 10.1038/nrc2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc2011</ArticleId><ArticleId IdType="pubmed">17093504</ArticleId></ArticleIdList></Reference><Reference><Citation>Louveau A., Smirnov I., Keyes T.J., Eccles J.D., Rouhani S.J., Peske J.D., Derecki N.C., Castle D., Mandell J.W., Lee K.S., et al. Structural and Functional Features of Central Nervous System Lymphatic Vessels. Nature. 2015;523:337&#x2013;341. doi: 10.1038/nature14432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14432</ArticleId><ArticleId IdType="pmc">PMC4506234</ArticleId><ArticleId IdType="pubmed">26030524</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakker E.N.T.P., Bacskai B.J., Arbel-Ornath M., Aldea R., Bedussi B., Morris A.W.J., Weller R.O., Carare R.O. Lymphatic Clearance of the Brain: Perivascular, Paravascular and Significance for Neurodegenerative Diseases. Cell. Mol. Neurobiol. 2016;36:181&#x2013;194. doi: 10.1007/s10571-015-0273-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-015-0273-8</ArticleId><ArticleId IdType="pmc">PMC4844641</ArticleId><ArticleId IdType="pubmed">26993512</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Henderson R.D., David M., McCombe P.A. Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. PLoS ONE. 2016;11:e0164625. doi: 10.1371/journal.pone.0164625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0164625</ArticleId><ArticleId IdType="pmc">PMC5061412</ArticleId><ArticleId IdType="pubmed">27732645</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe P.A., Henderson R.D. The Role of Immune and Inflammatory Mechanisms in ALS. Curr. Mol. Med. 2011;11:246&#x2013;254. doi: 10.2174/156652411795243450.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652411795243450</ArticleId><ArticleId IdType="pmc">PMC3182412</ArticleId><ArticleId IdType="pubmed">21375489</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.Y., Pfluger C.M., Henderson R.D., McCombe P.A. Reduced Levels of Interleukin 33 and Increased Levels of Soluble ST2 in Subjects with Amyotrophic Lateral Sclerosis. J. Neuroimmunol. 2012;249:93&#x2013;95. doi: 10.1016/j.jneuroim.2012.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2012.05.001</ArticleId><ArticleId IdType="pubmed">22633272</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani S., Gordon R., Macmaw J.K., Pfluger C.M.M., Henderson R.D., Noakes P.G., McCombe P.A., Woodruff T.M. Elevation of the Terminal Complement Activation Products C5a and C5b-9 in ALS Patient Blood. J. Neuroimmunol. 2014;276:213&#x2013;218. doi: 10.1016/j.jneuroim.2014.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2014.09.005</ArticleId><ArticleId IdType="pubmed">25262158</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe P.A., Pfluger C., Singh P., Lim C.Y.H., Airey C., Henderson R.D. Serial Measurements of Phosphorylated Neurofilament-Heavy in the Serum of Subjects with Amyotrophic Lateral Sclerosis. J. Neurol. Sci. 2015;353:122&#x2013;129. doi: 10.1016/j.jns.2015.04.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2015.04.032</ArticleId><ArticleId IdType="pubmed">25958264</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo S.T., Steyn F.J., Huang L., Mantovani S., Pfluger C.M.M., Woodruff T.M., O&#x2019;Sullivan J.D., Henderson R.D., McCombe P.A. Altered Expression of Metabolic Proteins and Adipokines in Patients with Amyotrophic Lateral Sclerosis. J. Neurol. Sci. 2015;357:22&#x2013;27. doi: 10.1016/j.jns.2015.06.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2015.06.053</ArticleId><ArticleId IdType="pubmed">26198021</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannides Z.A., Ngo S.T., Henderson R.D., McCombe P.A., Steyn F.J. Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression. Neurodegener Dis. 2016;16:382&#x2013;397. doi: 10.1159/000446502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000446502</ArticleId><ArticleId IdType="pubmed">27400276</ArticleId></ArticleIdList></Reference><Reference><Citation>Geyer P.E., Holdt L.M., Teupser D., Mann M. Revisiting Biomarker Discovery by Plasma Proteomics. Mol. Syst. Biol. 2017;13:942. doi: 10.15252/msb.20156297.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20156297</ArticleId><ArticleId IdType="pmc">PMC5615924</ArticleId><ArticleId IdType="pubmed">28951502</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellei E., Bergamini S., Monari E., Fantoni L.I., Cuoghi A., Ozben T., Tomasi A. High-Abundance Proteins Depletion for Serum Proteomic Analysis: Concomitant Removal of Non-Targeted Proteins. Amino Acids. 2011;40:145&#x2013;156. doi: 10.1007/s00726-010-0628-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-010-0628-x</ArticleId><ArticleId IdType="pubmed">20495836</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinz M., Priller J. Tickets to the Brain: Role of CCR2 and CX3CR1 in Myeloid Cell Entry in the CNS. J. Neuroimmunol. 2010;224:80&#x2013;84. doi: 10.1016/j.jneuroim.2010.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2010.05.015</ArticleId><ArticleId IdType="pubmed">20554025</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson L.L., Bilbo S.D. Chemokines and the Hippocampus: A New Perspective on Hippocampal Plasticity and Vulnerability. Brain Behav. Immun. 2013;30:186&#x2013;194. doi: 10.1016/j.bbi.2013.01.077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2013.01.077</ArticleId><ArticleId IdType="pubmed">23376170</ArticleId></ArticleIdList></Reference><Reference><Citation>Rost&#xe8;ne W., Dansereau M.-A., Godefroy D., van Steenwinckel J., Goazigo A.R.-L., M&#xe9;lik-Parsadaniantz S., Apartis E., Hunot S., Beaudet N., Sarret P. Neurochemokines: A Menage a Trois Providing New Insights on the Functions of Chemokines in the Central Nervous System. J. Neurochem. 2011;118:680&#x2013;694. doi: 10.1111/j.1471-4159.2011.07371.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07371.x</ArticleId><ArticleId IdType="pubmed">21722132</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransohoff R.M. Chemokines and Chemokine Receptors: Standing at the Crossroads of Immunobiology and Neurobiology. Immunity. 2009;31:711&#x2013;721. doi: 10.1016/j.immuni.2009.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2009.09.010</ArticleId><ArticleId IdType="pmc">PMC2787682</ArticleId><ArticleId IdType="pubmed">19836265</ArticleId></ArticleIdList></Reference><Reference><Citation>De Haas A.H., van Weering H.R.J., de Jong E.K., Boddeke H.W.G.M., Biber K.P.H. Neuronal Chemokines: Versatile Messengers in Central Nervous System Cell Interaction. Mol. Neurobiol. 2007;36:137&#x2013;151. doi: 10.1007/s12035-007-0036-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-007-0036-8</ArticleId><ArticleId IdType="pmc">PMC2039784</ArticleId><ArticleId IdType="pubmed">17952658</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J.S., Beers D.R., Sikl&#xf3;s L., Appel S.H. The Chemokine MCP-1 and the Dendritic and Myeloid Cells It Attracts Are Increased in the MSOD1 Mouse Model of ALS. Mol. Cell. Neurosci. 2006;31:427&#x2013;437. doi: 10.1016/j.mcn.2005.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2005.10.016</ArticleId><ArticleId IdType="pubmed">16337133</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Martinez L., Calvo A.C., Mu&#xf1;oz M.J., Osta R. Are Circulating Cytokines Reliable Biomarkers for Amyotrophic Lateral Sclerosis? Int. J. Mol. Sci. 2019;20:2759. doi: 10.3390/ijms20112759.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20112759</ArticleId><ArticleId IdType="pmc">PMC6600567</ArticleId><ArticleId IdType="pubmed">31195629</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa T., Matsui N., Fujita K., Miyashiro A., Nodera H., Izumi Y., Shimizu F., Miyamoto K., Takahashi Y., Kanda T., et al. Increased Proinflammatory Cytokines in Sera of Patients with Multifocal Motor Neuropathy. J. Neurol. Sci. 2014;346:75&#x2013;79. doi: 10.1016/j.jns.2014.07.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.07.059</ArticleId><ArticleId IdType="pubmed">25130929</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe9;s-Benito P., Moreno J., Dom&#xed;nguez R., Aso E., Povedano M., Ferrer I. Inflammatory Gene Expression in Whole Peripheral Blood at Early Stages of Sporadic Amyotrophic Lateral Sclerosis. Front. Neurol. 2017;8:546. doi: 10.3389/fneur.2017.00546.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00546</ArticleId><ArticleId IdType="pmc">PMC5645505</ArticleId><ArticleId IdType="pubmed">29081763</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters S., Zitzelsperger E., Kuespert S., Iberl S., Heydn R., Johannesen S., Petri S., Aigner L., Thal D.R., Hermann A., et al. The TGF-&#x3b2; System As a Potential Pathogenic Player in Disease Modulation of Amyotrophic Lateral Sclerosis. Front. Neurol. 2017;8:669. doi: 10.3389/fneur.2017.00669.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00669</ArticleId><ArticleId IdType="pmc">PMC5736544</ArticleId><ArticleId IdType="pubmed">29326641</ArticleId></ArticleIdList></Reference><Reference><Citation>Camu W., Mickunas M., Veyrune J.-L., Payan C., Garlanda C., Locati M., Juntas-Morales R., Pageot N., Malaspina A., Andreasson U., et al. Repeated 5-Day Cycles of Low Dose Aldesleukin in Amyotrophic Lateral Sclerosis (IMODALS): A Phase 2a Randomised, Double-Blind, Placebo-Controlled Trial. EBioMedicine. 2020;59:102844. doi: 10.1016/j.ebiom.2020.102844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102844</ArticleId><ArticleId IdType="pmc">PMC7502670</ArticleId><ArticleId IdType="pubmed">32651161</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Chen S.-E., Jin B., Carson J.A., Niu A., Durham W., Lai J.-Y., Li Y.-P. TIMP3: A Physiological Regulator of Adult Myogenesis. J. Cell Sci. 2010;123:2914&#x2013;2921. doi: 10.1242/jcs.057620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.057620</ArticleId><ArticleId IdType="pmc">PMC2923569</ArticleId><ArticleId IdType="pubmed">20682640</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Pacheco G.A., Garza-Veloz I., Castruita-De la Rosa C., Ramirez-Acu&#xf1;a J.M., Perez-Romero B.A., Guerrero-Rodriguez J.F., Martinez-Avila N., Martinez-Fierro M.L. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases. Int. J. Mol. Sci. 2020;21:9739. doi: 10.3390/ijms21249739.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21249739</ArticleId><ArticleId IdType="pmc">PMC7767220</ArticleId><ArticleId IdType="pubmed">33419373</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham L.A., Wetzel M., Rosenberg G.A. Multiple Roles for MMPs and TIMPs in Cerebral Ischemia. Glia. 2005;50:329&#x2013;339. doi: 10.1002/glia.20169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20169</ArticleId><ArticleId IdType="pubmed">15846802</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.H., Cho S.-J., Jo C., Park M.H., Han C., Kim E.-J., Huh G.Y., Koh Y.H. Altered TIMP-3 Levels in the Cerebrospinal Fluid and Plasma of Patients with Alzheimer&#x2019;s Disease. J. Pers. Med. 2022;12:827. doi: 10.3390/jpm12050827.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12050827</ArticleId><ArticleId IdType="pmc">PMC9144624</ArticleId><ArticleId IdType="pubmed">35629249</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.K., Shin J.H., Suh J., Choi I.S., Ryu K.S., Gwag B.J. Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) Expression Is Increased during Serum Deprivation-Induced Neuronal Apoptosis in Vitro and in the G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Potential Modulator of Fas-Mediated Apoptosis. Neurobiol. Dis. 2008;30:174&#x2013;185. doi: 10.1016/j.nbd.2008.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.01.004</ArticleId><ArticleId IdType="pubmed">18316197</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudo L.C., Parfenova L., Vi N., Lau K., Pomakian J., Valdmanis P., Rouleau G.A., Vinters H.V., Wiedau-Pazos M., Karsten S.L. Integrative Gene&#x2013;Tissue Microarray-Based Approach for Identification of Human Disease Biomarkers: Application to Amyotrophic Lateral Sclerosis. Hum. Mol. Genet. 2010;19:3233&#x2013;3253. doi: 10.1093/hmg/ddq232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq232</ArticleId><ArticleId IdType="pubmed">20530642</ArticleId></ArticleIdList></Reference><Reference><Citation>Timpl R., Brown J.C. Supramolecular Assembly of Basement Membranes. BioEssays. 1996;18:123&#x2013;132. doi: 10.1002/bies.950180208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.950180208</ArticleId><ArticleId IdType="pubmed">8851045</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader B.L., Smyth N., Nedbal S., Miosge N., Baranowsky A., Mokkapati S., Murshed M., Nischt R. Compound Genetic Ablation of Nidogen 1 and 2 Causes Basement Membrane Defects and Perinatal Lethality in Mice. Mol. Cell. Biol. 2005;25:6846&#x2013;6856. doi: 10.1128/MCB.25.15.6846-6856.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.25.15.6846-6856.2005</ArticleId><ArticleId IdType="pmc">PMC1190363</ArticleId><ArticleId IdType="pubmed">16024816</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel T.R., Bernards C., Meier M., McEleney K., Winzor D.J., Koch M., Stetefeld J. Structural Elucidation of Full-Length Nidogen and the Laminin&#x2013;Nidogen Complex in Solution. Matrix Biol. 2014;33:60&#x2013;67. doi: 10.1016/j.matbio.2013.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2013.07.009</ArticleId><ArticleId IdType="pubmed">23948589</ArticleId></ArticleIdList></Reference><Reference><Citation>Murshed M., Smyth N., Miosge N., Karolat J., Krieg T., Paulsson M., Nischt R. The Absence of Nidogen 1 Does Not Affect Murine Basement Membrane Formation. Mol. Cell. Biol. 2000;20:7007&#x2013;7012. doi: 10.1128/MCB.20.18.7007-7012.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.20.18.7007-7012.2000</ArticleId><ArticleId IdType="pmc">PMC88775</ArticleId><ArticleId IdType="pubmed">10958695</ArticleId></ArticleIdList></Reference><Reference><Citation>Schymeinsky J., Nedbal S., Miosge N., P&#xf6;schl E., Rao C., Beier D.R., Skarnes W.C., Timpl R., Bader B.L. Gene Structure and Functional Analysis of the Mouse Nidogen-2 Gene: Nidogen-2 Is Not Essential for Basement Membrane Formation in Mice. Mol. Cell. Biol. 2002;22:6820&#x2013;6830. doi: 10.1128/MCB.22.19.6820-6830.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.22.19.6820-6830.2002</ArticleId><ArticleId IdType="pmc">PMC135501</ArticleId><ArticleId IdType="pubmed">12215539</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong L., Chen Y., Lewis M., Hsieh J.-C., Reing J., Chaillet J.R., Howell C.Y., Melhem M., Inoue S., Kuszak J.R., et al. Neurologic Defects and Selective Disruption of Basement Membranes in Mice Lacking Entactin-1/Nidogen-1. Lab. Investig. 2002;82:1617&#x2013;1630. doi: 10.1097/01.LAB.0000042240.52093.0F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.LAB.0000042240.52093.0F</ArticleId><ArticleId IdType="pubmed">12480912</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasudevan A., Ho M.S.P., Weiergr&#xe4;ber M., Nischt R., Schneider T., Lie A., Smyth N., K&#xf6;hling R. Basement Membrane Protein Nidogen-1 Shapes Hippocampal Synaptic Plasticity and Excitability. Hippocampus. 2010;20:608&#x2013;620. doi: 10.1002/hipo.20660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hipo.20660</ArticleId><ArticleId IdType="pubmed">19530222</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox J.W., Mayer U., Nischt R., Aumailley M., Reinhardt D., Wiedemann H., Mann K., Timpl R., Krieg T., Engel J. Recombinant Nidogen Consists of Three Globular Domains and Mediates Binding of Laminin to Collagen Type IV. EMBO J. 1991;10:3137&#x2013;3146. doi: 10.1002/j.1460-2075.1991.tb04875.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1460-2075.1991.tb04875.x</ArticleId><ArticleId IdType="pmc">PMC453035</ArticleId><ArticleId IdType="pubmed">1717261</ArticleId></ArticleIdList></Reference><Reference><Citation>Keable A., Fenna K., Yuen H.M., Johnston D.A., Smyth N.R., Smith C., Salman R.A.-S., Samarasekera N., Nicoll J.A.R., Attems J., et al. Deposition of Amyloid &#x3b2; in the Walls of Human Leptomeningeal Arteries in Relation to Perivascular Drainage Pathways in Cerebral Amyloid Angiopathy. Biochim. Biophys. Acta BBA-Mol. Basis Dis. 2016;1862:1037&#x2013;1046. doi: 10.1016/j.bbadis.2015.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2015.08.024</ArticleId><ArticleId IdType="pmc">PMC4827375</ArticleId><ArticleId IdType="pubmed">26327684</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.-X., et al. Motor Neuron Degeneration in Mice That Express a Human Cu,Zn Superoxide Dismutase Mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Crociara P., Chieppa M.N., Vallino Costassa E., Berrone E., Gallo M., lo Faro M., Pintore M.D., Iulini B., D&#x2019;Angelo A., Perona G., et al. Motor Neuron Degeneration, Severe Myopathy and TDP-43 Increase in a Transgenic Pig Model of SOD1-Linked Familiar ALS. Neurobiol. Dis. 2019;124:263&#x2013;275. doi: 10.1016/j.nbd.2018.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.11.021</ArticleId><ArticleId IdType="pubmed">30471417</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudet P., Livstone M.S., Lewis S.E., Thomas P.D. Phylogenetic-Based Propagation of Functional Annotations within the Gene Ontology Consortium. Brief. Bioinform. 2011;12:449&#x2013;462. doi: 10.1093/bib/bbr042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbr042</ArticleId><ArticleId IdType="pmc">PMC3178059</ArticleId><ArticleId IdType="pubmed">21873635</ArticleId></ArticleIdList></Reference><Reference><Citation>Naba A., Pearce O.M.T., del Rosario A., Ma D., Ding H., Rajeeve V., Cutillas P.R., Balkwill F.R., Hynes R.O. Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. J. Proteome Res. 2017;16:3083&#x2013;3091. doi: 10.1021/acs.jproteome.7b00191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.7b00191</ArticleId><ArticleId IdType="pmc">PMC8078728</ArticleId><ArticleId IdType="pubmed">28675934</ArticleId></ArticleIdList></Reference><Reference><Citation>KOCH S., KOHL K., KLEIN E., VONBUBNOFF D., BIEBER T. Skin Homing of Langerhans Cell Precursors: Adhesion, Chemotaxis, and Migration. J. Allergy Clin. Immunol. 2006;117:163&#x2013;168. doi: 10.1016/j.jaci.2005.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2005.10.003</ArticleId><ArticleId IdType="pubmed">16387601</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedl P., Br&#xf6;cker E.-B. Cell Migration in Inflammation and Immunity. Humana Press; Totowa, NJ, USA: 2003. Reconstructing Leukocyte Migration in 3D Extracellular Matrix by Time-Lapse Videomicroscopy and Computer-Assisted Tracking; pp. 77&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">14573911</ArticleId></ArticleIdList></Reference><Reference><Citation>Savino W., Mendes-da-Cruz D.A., Silva J.S., Dardenne M., Cotta-de-Almeida V. Intrathymic T-Cell Migration: A Combinatorial Interplay of Extracellular Matrix and Chemokines? Trends Immunol. 2002;23:305&#x2013;313. doi: 10.1016/S1471-4906(02)02224-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1471-4906(02)02224-X</ArticleId><ArticleId IdType="pubmed">12072370</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi A., Mayr M. In Aptamers They Trust: The Caveats of the SOMAscan Biomarker Discovery Platform from SomaLogic. Circulation. 2018;138:2482&#x2013;2485. doi: 10.1161/CIRCULATIONAHA.118.036823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.036823</ArticleId><ArticleId IdType="pmc">PMC6277005</ArticleId><ArticleId IdType="pubmed">30524136</ArticleId></ArticleIdList></Reference><Reference><Citation>Peviani M., Caron I., Pizzasegola C., Gensano F., Tortarolo M., Bendotti C. Unraveling the Complexity of Amyotrophic Lateral Sclerosis: Recent Advances from the Transgenic Mutant SOD1 Mice. CNS Neurol. Disord. Drug Targets. 2010;9:491&#x2013;503. doi: 10.2174/187152710791556096.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152710791556096</ArticleId><ArticleId IdType="pubmed">20522008</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Canosa A., Gallo S., Moglia C., Ilardi A., Cammarosano S., Papurello D., Calvo A. Pain in Amyotrophic Lateral Sclerosis: A Population-Based Controlled Study. Eur. J. Neurol. 2012;19:551&#x2013;555. doi: 10.1111/j.1468-1331.2011.03540.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03540.x</ArticleId><ArticleId IdType="pubmed">21972798</ArticleId></ArticleIdList></Reference><Reference><Citation>De Groote M.A., Nahid P., Jarlsberg L., Johnson J.L., Weiner M., Muzanyi G., Janjic N., Sterling D.G., Ochsner U.A. Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment. PLoS ONE. 2013;8:e61002. doi: 10.1371/journal.pone.0061002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0061002</ArticleId><ArticleId IdType="pmc">PMC3630118</ArticleId><ArticleId IdType="pubmed">23637781</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold L., Ayers D., Bertino J., Bock C., Bock A., Brody E.N., Carter J., Dalby A.B., Eaton B.E., Fitzwater T., et al. Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery. PLoS ONE. 2010;5:e15004. doi: 10.1371/journal.pone.0015004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015004</ArticleId><ArticleId IdType="pmc">PMC3000457</ArticleId><ArticleId IdType="pubmed">21165148</ArticleId></ArticleIdList></Reference><Reference><Citation>Tusher V.G., Tibshirani R., Chu G. Significance Analysis of Microarrays Applied to the Ionizing Radiation Response. Proc. Natl. Acad. Sci. USA. 2001;98:5116&#x2013;5121. doi: 10.1073/pnas.091062498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.091062498</ArticleId><ArticleId IdType="pmc">PMC33173</ArticleId><ArticleId IdType="pubmed">11309499</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Chen J., Liu H., Chen S., Zhang Y., Li P., Thierry-Mieg D., Thierry-Mieg J., Mattes W., Ning B., et al. Comprehensive Identification and Characterization of Human Secretome Based on Integrative Proteomic and Transcriptomic Data. Front. Cell Dev. Biol. 2019;7:299. doi: 10.3389/fcell.2019.00299.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2019.00299</ArticleId><ArticleId IdType="pmc">PMC6881247</ArticleId><ArticleId IdType="pubmed">31824949</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>